 Connection
Mark Lovell to Amyloid beta-Peptides
This is a "connection" page, showing publications Mark Lovell has written about Amyloid beta-Peptides.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.722 |
|
|
|
-
Xiong S, Markesbery WR, Shao C, Lovell MA. Seleno-L-methionine protects against beta-amyloid and iron/hydrogen peroxide-mediated neuron death. Antioxid Redox Signal. 2007 Apr; 9(4):457-67.
Score: 0.239
-
Lovell MA, Markesbery WR. Amyloid beta peptide, 4-hydroxynonenal and apoptosis. Curr Alzheimer Res. 2006 Sep; 3(4):359-64.
Score: 0.229
-
Lovell MA, Xiong S, Markesbery WR, Lynn BC. Quantitative proteomic analysis of mitochondria from primary neuron cultures treated with amyloid beta peptide. Neurochem Res. 2005 Jan; 30(1):113-22.
Score: 0.204
-
Lovell MA, Xie C, Xiong S, Markesbery WR. Protection against amyloid beta peptide and iron/hydrogen peroxide toxicity by alpha lipoic acid. J Alzheimers Dis. 2003 Jun; 5(3):229-39.
Score: 0.183
-
Lovell MA, Xie C, Markesbery WR. Protection against amyloid beta peptide toxicity by zinc. Brain Res. 1999 Mar 27; 823(1-2):88-95.
Score: 0.137
-
Sompol P, Furman JL, Pleiss MM, Kraner SD, Artiushin IA, Batten SR, Quintero JE, Simmerman LA, Beckett TL, Lovell MA, Murphy MP, Gerhardt GA, Norris CM. Calcineurin/NFAT Signaling in Activated Astrocytes Drives Network Hyperexcitability in A?-Bearing Mice. J Neurosci. 2017 06 21; 37(25):6132-6148.
Score: 0.121
-
Lovell MA, Lynn BC, Fister S, Bradley-Whitman M, Murphy MP, Beckett TL, Norris CM. A Novel Small Molecule Modulator of Amyloid Pathology. J Alzheimers Dis. 2016 05 04; 53(1):273-87.
Score: 0.112
-
Lovell MA, Abner E, Kryscio R, Xu L, Fister SX, Lynn BC. Calcium Channel Blockers, Progression to Dementia, and Effects on Amyloid Beta Peptide Production. Oxid Med Cell Longev. 2015; 2015:787805.
Score: 0.106
-
Bradley-Whitman MA, Abner E, Lynn BC, Lovell MA. A Novel Plasma Based Biomarker of Alzheimer's Disease. J Alzheimers Dis. 2015; 47(3):761-71.
Score: 0.102
-
Lyubartseva G, Lovell MA. A potential role for zinc alterations in the pathogenesis of Alzheimer's disease. Biofactors. 2012 Mar-Apr; 38(2):98-106.
Score: 0.084
-
Weidner AM, Bradley MA, Beckett TL, Niedowicz DM, Dowling AL, Matveev SV, LeVine H, Lovell MA, Murphy MP. RNA oxidation adducts 8-OHG and 8-OHA change with A?42 levels in late-stage Alzheimer's disease. PLoS One. 2011; 6(9):e24930.
Score: 0.081
-
Lovell MA, Xie C, Xiong S, Markesbery WR. Wilms' tumor suppressor (WT1) is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer's disease. Brain Res. 2003 Sep 05; 983(1-2):84-96.
Score: 0.047
-
Lovell MA, Xie C, Gabbita SP, Markesbery WR. Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain. Free Radic Biol Med. 2000 Feb 01; 28(3):418-27.
Score: 0.036
-
Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J Neurochem. 1997 Jan; 68(1):255-64.
Score: 0.029
-
Xie C, Lovell MA, Xiong S, Kindy MS, Guo J, Xie J, Amaranth V, Montine TJ, Markesbery WR. Expression of glutathione-S-transferase isozyme in the SY5Y neuroblastoma cell line increases resistance to oxidative stress. Free Radic Biol Med. 2001 Jul 01; 31(1):73-81.
Score: 0.010
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|